The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Corticosteroid Medication Market Research Report 2024
Synopsis
Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma.
Global Corticosteroid Medication market is projected to reach US$ 6690.5 million in 2029, increasing from US$ 4850 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Corticosteroid Medication market research.
Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Corticosteroid Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
GSK
AstraZeneca
Cipla
LEO Pharma
Abbott Laboratories
Bayer
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Zhejiang Xianju Pharmaceutical Co.,Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group
Segment by Type
Tablets
Capsules
Eye Drops
Lotions, Creams, Ointments, or Gels
Nasal or Mouth Sprays
Injections
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Corticosteroid Medication report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Corticosteroids are synthetic analogs of the natural steroid hormones produced by the adrenal cortex and include glucocorticoids and mineralocorticoids. The synthetic hormones have varying degrees of glucocorticoid and mineralocorticoid properties. Glucocorticoids are predominantly involved in metabolism and have immunosuppressive, anti-inflammatory, and vasoconstrictive effects. Corticosteroid drugs (including cortisone, hydrocortisone and prednisone) are useful in treating many conditions, such as rashes, inflammatory bowel disease and asthma.
Global Corticosteroid Medication market is projected to reach US$ 6690.5 million in 2029, increasing from US$ 4850 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Corticosteroid Medication market research.
Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Corticosteroid Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
GSK
AstraZeneca
Cipla
LEO Pharma
Abbott Laboratories
Bayer
Tianjin Tianyao Pharmaceuticals Co., Ltd.
Zhejiang Xianju Pharmaceutical Co.,Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group
Segment by Type
Tablets
Capsules
Eye Drops
Lotions, Creams, Ointments, or Gels
Nasal or Mouth Sprays
Injections
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Corticosteroid Medication report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Corticosteroid Medication Market Overview
1.1 Product Overview and Scope of Corticosteroid Medication
1.2 Corticosteroid Medication Segment by Type
1.2.1 Global Corticosteroid Medication Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Eye Drops
1.2.5 Lotions, Creams, Ointments, or Gels
1.2.6 Nasal or Mouth Sprays
1.2.7 Injections
1.3 Corticosteroid Medication Segment by Application
1.3.1 Global Corticosteroid Medication Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Corticosteroid Medication Market Size Estimates and Forecasts
1.4.1 Global Corticosteroid Medication Revenue 2018-2029
1.4.2 Global Corticosteroid Medication Sales 2018-2029
1.4.3 Global Corticosteroid Medication Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Corticosteroid Medication Market Competition by Manufacturers
2.1 Global Corticosteroid Medication Sales Market Share by Manufacturers (2018-2023)
2.2 Global Corticosteroid Medication Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Corticosteroid Medication Average Price by Manufacturers (2018-2023)
2.4 Global Corticosteroid Medication Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Corticosteroid Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Corticosteroid Medication, Product Type & Application
2.7 Corticosteroid Medication Market Competitive Situation and Trends
2.7.1 Corticosteroid Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Corticosteroid Medication Players Market Share by Revenue
2.7.3 Global Corticosteroid Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Corticosteroid Medication Retrospective Market Scenario by Region
3.1 Global Corticosteroid Medication Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Corticosteroid Medication Global Corticosteroid Medication Sales by Region: 2018-2029
3.2.1 Global Corticosteroid Medication Sales by Region: 2018-2023
3.2.2 Global Corticosteroid Medication Sales by Region: 2024-2029
3.3 Global Corticosteroid Medication Global Corticosteroid Medication Revenue by Region: 2018-2029
3.3.1 Global Corticosteroid Medication Revenue by Region: 2018-2023
3.3.2 Global Corticosteroid Medication Revenue by Region: 2024-2029
3.4 North America Corticosteroid Medication Market Facts & Figures by Country
3.4.1 North America Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Corticosteroid Medication Sales by Country (2018-2029)
3.4.3 North America Corticosteroid Medication Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Corticosteroid Medication Market Facts & Figures by Country
3.5.1 Europe Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Corticosteroid Medication Sales by Country (2018-2029)
3.5.3 Europe Corticosteroid Medication Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Corticosteroid Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Corticosteroid Medication Sales by Country (2018-2029)
3.6.3 Asia Pacific Corticosteroid Medication Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Corticosteroid Medication Market Facts & Figures by Country
3.7.1 Latin America Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Corticosteroid Medication Sales by Country (2018-2029)
3.7.3 Latin America Corticosteroid Medication Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Corticosteroid Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Corticosteroid Medication Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Corticosteroid Medication Sales by Country (2018-2029)
3.8.3 Middle East and Africa Corticosteroid Medication Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Corticosteroid Medication Sales by Type (2018-2029)
4.1.1 Global Corticosteroid Medication Sales by Type (2018-2023)
4.1.2 Global Corticosteroid Medication Sales by Type (2024-2029)
4.1.3 Global Corticosteroid Medication Sales Market Share by Type (2018-2029)
4.2 Global Corticosteroid Medication Revenue by Type (2018-2029)
4.2.1 Global Corticosteroid Medication Revenue by Type (2018-2023)
4.2.2 Global Corticosteroid Medication Revenue by Type (2024-2029)
4.2.3 Global Corticosteroid Medication Revenue Market Share by Type (2018-2029)
4.3 Global Corticosteroid Medication Price by Type (2018-2029)
5 Segment by Application
5.1 Global Corticosteroid Medication Sales by Application (2018-2029)
5.1.1 Global Corticosteroid Medication Sales by Application (2018-2023)
5.1.2 Global Corticosteroid Medication Sales by Application (2024-2029)
5.1.3 Global Corticosteroid Medication Sales Market Share by Application (2018-2029)
5.2 Global Corticosteroid Medication Revenue by Application (2018-2029)
5.2.1 Global Corticosteroid Medication Revenue by Application (2018-2023)
5.2.2 Global Corticosteroid Medication Revenue by Application (2024-2029)
5.2.3 Global Corticosteroid Medication Revenue Market Share by Application (2018-2029)
5.3 Global Corticosteroid Medication Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sumitomo Corticosteroid Medication Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Corticosteroid Medication Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Corticosteroid Medication Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Corticosteroid Medication Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Corticosteroid Medication Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Corticosteroid Medication Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Corticosteroid Medication Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Corticosteroid Medication Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Corticosteroid Medication Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 LEO Pharma
6.10.1 LEO Pharma Corporation Information
6.10.2 LEO Pharma Description and Business Overview
6.10.3 LEO Pharma Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.10.4 LEO Pharma Corticosteroid Medication Product Portfolio
6.10.5 LEO Pharma Recent Developments/Updates
6.11 Abbott Laboratories
6.11.1 Abbott Laboratories Corporation Information
6.11.2 Abbott Laboratories Corticosteroid Medication Description and Business Overview
6.11.3 Abbott Laboratories Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Abbott Laboratories Corticosteroid Medication Product Portfolio
6.11.5 Abbott Laboratories Recent Developments/Updates
6.12 Bayer
6.12.1 Bayer Corporation Information
6.12.2 Bayer Corticosteroid Medication Description and Business Overview
6.12.3 Bayer Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bayer Corticosteroid Medication Product Portfolio
6.12.5 Bayer Recent Developments/Updates
6.13 Tianjin Tianyao Pharmaceuticals Co., Ltd.
6.13.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information
6.13.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Description and Business Overview
6.13.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corticosteroid Medication Product Portfolio
6.13.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.14 Zhejiang Xianju Pharmaceutical Co.,Ltd
6.14.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information
6.14.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Description and Business Overview
6.14.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Corticosteroid Medication Product Portfolio
6.14.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
6.15 Shandong Xinhua Pharmaceutical Company Limited
6.15.1 Shandong Xinhua Pharmaceutical Company Limited Corporation Information
6.15.2 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Description and Business Overview
6.15.3 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shandong Xinhua Pharmaceutical Company Limited Corticosteroid Medication Product Portfolio
6.15.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates
6.16 Yangzi River Pharmaceutical Group
6.16.1 Yangzi River Pharmaceutical Group Corporation Information
6.16.2 Yangzi River Pharmaceutical Group Corticosteroid Medication Description and Business Overview
6.16.3 Yangzi River Pharmaceutical Group Corticosteroid Medication Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Yangzi River Pharmaceutical Group Corticosteroid Medication Product Portfolio
6.16.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Corticosteroid Medication Industry Chain Analysis
7.2 Corticosteroid Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Corticosteroid Medication Production Mode & Process
7.4 Corticosteroid Medication Sales and Marketing
7.4.1 Corticosteroid Medication Sales Channels
7.4.2 Corticosteroid Medication Distributors
7.5 Corticosteroid Medication Customers
8 Corticosteroid Medication Market Dynamics
8.1 Corticosteroid Medication Industry Trends
8.2 Corticosteroid Medication Market Drivers
8.3 Corticosteroid Medication Market Challenges
8.4 Corticosteroid Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
